We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Alliance to Develop Biologic Detection Systems

By HospiMedica staff writers
Posted on 20 Aug 2001
A collaboration to develop and design biologic-detection systems for military and other preparedness applications has been announced by Environmental Technologies Group Inc. More...
(ETG, Baltimore, MD, USA) and Cepheid (Sunnyvale, CA, USA). Under the agreement, the two companies will develop systems based on Cepheid's proprietary technologies for the capture, purification, amplification, and detection of DNA.

Cepheid will provide subsystems and sub-assemblies to ETG for integration into, and manufacture of, fully automated bio-detection systems that will range from hand-held units to stationary monitoring systems for use in a variety of military and civilian settings. Cepheid's I-Core and microfluidic technologies will be key components of the DNA detection systems that will be made and marketed on a worldwide basis by ETG and its sister company, Graseby Dynamics Limited, under royalty-bearing licenses from Cepheid. ETG, a part of Smiths Aerospace (London, UK), is a leading provider of full-service, advanced engineering technology for nuclear, biologic, and chemical detection systems.

"ETG is the ideal partner to adapt Cepheid's versatile DNA testing technology to the bio-defense market, and together we are committed to developing systems that deliver faster, more sensitive results under any conditions,” said Tom Gutshall, chairman and CEO of Cepheid.




Related Links:
Cepheid
Graseby Dynamics

New
Gold Member
Automatic Hematology Analyzer
CF9600
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Repetitive Pipette
VWR® Stepper Pro
New
Hematology Consumables
Bioblood Devices
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: The device contains specific antibodies that capture the primary biomarker of pancreatic cancer. The binding of these antibodies alters the distribution of electrical charges on the electrode surface. The sensor then translates this variation into a measurable capacitance signal (photo courtesy of Gabriella Soares / IFSC-USP)

Rapid Biosensor Detects Pancreatic Cancer Biomarker for Early Detection

Pancreatic cancer is frequently identified only after it has progressed because early disease is typically asymptomatic, and survival remains extremely poor once advanced. Conventional laboratory assays... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.